<?xml version='1.0' encoding='utf-8'?>
<document id="22403324"><sentence text="Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers."><entity charOffset="34-46" id="DDI-PubMed.22403324.s1.e0" text="pyronaridine" /><entity charOffset="47-57" id="DDI-PubMed.22403324.s1.e1" text="artesunate" /><entity charOffset="62-71" id="DDI-PubMed.22403324.s1.e2" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.22403324.s1.e0" e2="DDI-PubMed.22403324.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s1.e0" e2="DDI-PubMed.22403324.s1.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s1.e0" e2="DDI-PubMed.22403324.s1.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s1.e1" e2="DDI-PubMed.22403324.s1.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s1.e1" e2="DDI-PubMed.22403324.s1.e2" /></sentence><sentence text="A multiple dose, parallel group study was conducted to assess for a drug-drug interaction between the pyronaridine/artesunate (PA) combination antimalarial and ritonavir"><entity charOffset="102-114" id="DDI-PubMed.22403324.s2.e0" text="pyronaridine" /><entity charOffset="115-125" id="DDI-PubMed.22403324.s2.e1" text="artesunate" /><entity charOffset="127-129" id="DDI-PubMed.22403324.s2.e2" text="PA" /><entity charOffset="160-169" id="DDI-PubMed.22403324.s2.e3" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e0" e2="DDI-PubMed.22403324.s2.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e0" e2="DDI-PubMed.22403324.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e0" e2="DDI-PubMed.22403324.s2.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e0" e2="DDI-PubMed.22403324.s2.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e1" e2="DDI-PubMed.22403324.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e1" e2="DDI-PubMed.22403324.s2.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e1" e2="DDI-PubMed.22403324.s2.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e2" e2="DDI-PubMed.22403324.s2.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s2.e2" e2="DDI-PubMed.22403324.s2.e3" /></sentence><sentence text=" Thirty-four healthy adults were randomized (1:1) to receive PA for 3 days or PA with ritonavir (100 mg twice daily for 17 days, PA administered on Days 8-10)"><entity charOffset="86-95" id="DDI-PubMed.22403324.s3.e0" text="ritonavir" /><entity charOffset="61-69" id="DDI-PubMed.22403324.s3.e1" text="PA" /><entity charOffset="78-86" id="DDI-PubMed.22403324.s3.e2" text="PA" /><entity charOffset="129-137" id="DDI-PubMed.22403324.s3.e3" text="PA" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e1" e2="DDI-PubMed.22403324.s3.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e1" e2="DDI-PubMed.22403324.s3.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e1" e2="DDI-PubMed.22403324.s3.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e1" e2="DDI-PubMed.22403324.s3.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e2" e2="DDI-PubMed.22403324.s3.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e2" e2="DDI-PubMed.22403324.s3.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e2" e2="DDI-PubMed.22403324.s3.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e0" e2="DDI-PubMed.22403324.s3.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s3.e0" e2="DDI-PubMed.22403324.s3.e3" /></sentence><sentence text=" Pharmacokinetic parameters for pyronaridine, artesunate, and its active metabolite dihydroartemisinin (DHA) were obtained after the last PA dose and for ritonavir on Days 1 and 10"><entity charOffset="32-44" id="DDI-PubMed.22403324.s4.e0" text="pyronaridine" /><entity charOffset="46-56" id="DDI-PubMed.22403324.s4.e1" text="artesunate" /><entity charOffset="84-102" id="DDI-PubMed.22403324.s4.e2" text="dihydroartemisinin" /><entity charOffset="104-107" id="DDI-PubMed.22403324.s4.e3" text="DHA" /><entity charOffset="154-163" id="DDI-PubMed.22403324.s4.e4" text="ritonavir" /><entity charOffset="138-146" id="DDI-PubMed.22403324.s4.e5" text="PA" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e0" e2="DDI-PubMed.22403324.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e0" e2="DDI-PubMed.22403324.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e0" e2="DDI-PubMed.22403324.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e0" e2="DDI-PubMed.22403324.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e0" e2="DDI-PubMed.22403324.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e0" e2="DDI-PubMed.22403324.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e1" e2="DDI-PubMed.22403324.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e1" e2="DDI-PubMed.22403324.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e1" e2="DDI-PubMed.22403324.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e1" e2="DDI-PubMed.22403324.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e1" e2="DDI-PubMed.22403324.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e2" e2="DDI-PubMed.22403324.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e2" e2="DDI-PubMed.22403324.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e2" e2="DDI-PubMed.22403324.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e2" e2="DDI-PubMed.22403324.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e3" e2="DDI-PubMed.22403324.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e3" e2="DDI-PubMed.22403324.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e3" e2="DDI-PubMed.22403324.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e5" e2="DDI-PubMed.22403324.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22403324.s4.e5" e2="DDI-PubMed.22403324.s4.e4" /></sentence><sentence text=" Ritonavir coadministration did not markedly change pyronaridine pharmacokinetics but resulted in a 27% increase in artesunate area under the curve (AUC) and a 38% decrease in DHA AUC"><entity charOffset="1-10" id="DDI-PubMed.22403324.s5.e0" text="Ritonavir" /><entity charOffset="52-64" id="DDI-PubMed.22403324.s5.e1" text="pyronaridine" /><entity charOffset="116-126" id="DDI-PubMed.22403324.s5.e2" text="artesunate" /><entity charOffset="176-185" id="DDI-PubMed.22403324.s5.e3" text="DHA" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e0" e2="DDI-PubMed.22403324.s5.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e0" e2="DDI-PubMed.22403324.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e0" e2="DDI-PubMed.22403324.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e0" e2="DDI-PubMed.22403324.s5.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e1" e2="DDI-PubMed.22403324.s5.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e1" e2="DDI-PubMed.22403324.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e1" e2="DDI-PubMed.22403324.s5.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e2" e2="DDI-PubMed.22403324.s5.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s5.e2" e2="DDI-PubMed.22403324.s5.e3" /></sentence><sentence text=" Ritonavir exposure was increased 3"><entity charOffset="1-10" id="DDI-PubMed.22403324.s6.e0" text="Ritonavir" /></sentence><sentence text="2-fold in the presence of PA"><entity charOffset="26-34" id="DDI-PubMed.22403324.s7.e0" text="PA" /></sentence><sentence text=" The only relevant safety observations were increases in liver enzymes, only reaching a clinically significant grade in the PA + ritonavir arm"><entity charOffset="124-138" id="DDI-PubMed.22403324.s8.e0" text="PA + ritonavir" /></sentence><sentence text=" It was concluded that coadministered ritonavir and PA interact to alter exposure to artesunate, DHA, and ritonavir itself"><entity charOffset="38-47" id="DDI-PubMed.22403324.s9.e0" text="ritonavir" /><entity charOffset="52-54" id="DDI-PubMed.22403324.s9.e1" text="PA" /><entity charOffset="85-95" id="DDI-PubMed.22403324.s9.e2" text="artesunate" /><entity charOffset="97-100" id="DDI-PubMed.22403324.s9.e3" text="DHA" /><entity charOffset="106-115" id="DDI-PubMed.22403324.s9.e4" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e0" e2="DDI-PubMed.22403324.s9.e0" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e0" e2="DDI-PubMed.22403324.s9.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e0" e2="DDI-PubMed.22403324.s9.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e0" e2="DDI-PubMed.22403324.s9.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e0" e2="DDI-PubMed.22403324.s9.e4" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e1" e2="DDI-PubMed.22403324.s9.e1" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e1" e2="DDI-PubMed.22403324.s9.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e1" e2="DDI-PubMed.22403324.s9.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e1" e2="DDI-PubMed.22403324.s9.e4" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e2" e2="DDI-PubMed.22403324.s9.e2" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e2" e2="DDI-PubMed.22403324.s9.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e2" e2="DDI-PubMed.22403324.s9.e4" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e3" e2="DDI-PubMed.22403324.s9.e3" /><pair ddi="false" e1="DDI-PubMed.22403324.s9.e3" e2="DDI-PubMed.22403324.s9.e4" /></sentence><sentence text="" /></document>